- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hitachi awaits news on nuclear options
Food and Drug Administration clearance is imminent for several advanced gamma camera options developed by Hitachi Medical Systems America. The Twinsburg, OH, vendor has already received 510(k) clearance for a 5/8-inch crystal option, and is
Food and Drug Administration clearance is imminent for several advanced gamma camera options developed by Hitachi Medical Systems America. The Twinsburg, OH, vendor has already received 510(k) clearance for a 5/8-inch crystal option, and is awaiting the agencys word on nonuniform attenuation correction and coincidence detection options, according to Gary Enos, general manager of the unit.
The upgrades are Hitachis final touches that will make its premium SpectraDigital V250DSP camera a full-featured system capable of high-energy imaging. Hitachi will highlight the options at next months Society of Nuclear Medicine meeting in Los Angeles.
Hitachi will also have its hands full explaining the nuclear medicine units direction in light of the companys new relationship with ADAC Laboratories of Milpitas, CA. Earlier this month, Hitachi announced that it would halt development of new gamma cameras in favor of distributing ADAC systems in Japan (SCAN 5/12/99). Hitachi is reviewing its nuclear business in light of the ADAC relationship, Enos said.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
